Nearly seven years ago, Colorado citizens—tired of the war on drugs and wise to the near-limitless benefits of cannabis—made US history by voting to legalize recreational marijuana. Now, this state has once again placed themselves on the right side of history as they voted this month to decriminalize magic mushrooms. But this was just the beginning and their momentum is spreading—faster and stronger, toward decriminalizing all plant-based psychedelics.
Now, a major city in California is following suit, but not just with psilocybin—Oakland is calling for decriminalization of other psychedelics like mescaline cacti, ayahuasca and ibogaine.
To be clear, the recent measure does not mean that mushrooms are now legal in Denver, it simply means that cops can’t make it a priority to go after folks for them and it won’t land people in jail for possession. While legalization would be the perfect result, this is most certainly a step in the right direction and this step appears to be a giant leap now that California is doing the same.
As Forbes reports:
The resolution, which would seek to bar police and other city officials from using “any city funds or resources to assist in the enforcement of laws imposing criminal penalties for the use and possession” of the plant- and fungi-based substances, has been scheduled for a hearing before the Oakland City Council’s Public Safety Committee on May 28.
If approved there, it would head to the full Council for a final vote.
Like the Denver resolution, the Oakland resolution would make possession of these psychedelics “amongst the lowest law enforcement priority” for the city under the measure, according to Forbes, which also specifies that the Council “wishes to declare its desire not to expend City resources in any investigation, detention, arrest, or prosecution arising out of alleged violations of state and federal law regarding the use of Entheogenic Plants.”
“We already have support from at least five members of the Council, but our goal is to get eight out of eight to show unanimous support, because this affects all communities in Oakland,” Carlos Plazola, an organizer with the group Decriminalize Nature, which worked to help draft the measure, said in an interview.
As TFTP has reported in the past, psilocybin-containing mushrooms are an enemy to the establishment who has every reason in the world to want to keep them as illegal as possible. The same goes for ayahuasca and other powerful mind-opening substances.
The United States Supreme Court has unanimously ruled in favor of the legal religious use of ayahuasca by the União do Vegetal, and the U.S. Court of Appeals for the Ninth Circuit has affirmed the Santo Daime Church’s freedom to use Ayahuasca for religious purposes. However, ayahuasca’s principally active ingredient, DMT, remains a Schedule I controlled substance, carrying a steep prison sentence.
Many people have been forced to travel outside of the country to meet with Shamans in the Amazon who are skilled and knowledgeable about the substance.
One industry in particular, Big Pharma, stands to lose billions if measures like this one began to spread to other areas as mushrooms and other hallucinogens have been clinically tested to treat a wide range of problems, including depression.
One in ten men in the US currently takes an antidepressant while 16.5 percent of women use them as well. If people can treat their depression with something that you can grow in your own home or a plant medicine from a shaman verses taking pills with side effects like homicidal ideation, the pharmaceutical industry would lose big time.
Indeed, there are mounds of evidence and studies showing the positive benefits of magic mushrooms, ayahuasca, and ibogaine.
As TFTP reported last year, a study, published in the scientific journal Neuropharmacology, found that clinically depressed people had increased neural responses to fearful faces one day after a psilocybin-assisted therapy session, which positively predicted positive clinical outcomes.
“Psilocybin-assisted therapy might mitigate depression by increasing emotional connection,” neuroscientist and study author Leor Roseman, a Ph.D. student at Imperial College London, explained to PsyPost.
This is almost the exact opposite of how standard anti-depressants operate, as SSRI’s typically work by creating an “emotional blunting.”
“[T]his is unlike SSRI antidepressants which are criticized for creating in many people a general emotional blunting,” noted Roseman.
“I believe that psychedelics hold a potential to cure deep psychological wounds, and I believe that by investigating their neuropsychopharmacological mechanism, we can learn to understand this potential,” explained Roseman.
The government also stands to lose if more measures like this take hold in other cities too.
As TFTP previously reported, mushrooms and psychedelics used to be widely accepted as a treatment for many ailments until government moved in to stop the expansion of human consciousness.
As MAPS points out, although first-hand accounts indicate that ibogaine is unlikely to be popular as a recreational drug, ibogaine remains classified as a Schedule I drug in the United States (it is also scheduled in Belgium and Switzerland). Yet despite its classification as a drug with a “high potential for abuse” and “no currently accepted medical use,” people who struggle with substance abuse continue to seek out international clinics or underground providers to receive ibogaine treatment.
In the 1940s, western medicine began realizing the potential for psychedelics to treat addiction and psychiatric disorders. Tens of thousands of people were treated effectively, and psychedelic drugs were on the fast track to becoming mainstream medicine. But the beast of oppression reared its ugly head.
In 1967 and 1970, the UK and US governments cast all psychedelic substances into the pit of prohibition. People were waking up to the fact that governments intended to keep the world in a state of war, and that governments were working to keep the populace sedated under a cloak of consumerism. The collective mind expansion of that era came to a screeching halt under the boot and truncheon.
As John Vibes pointed out last January, a study actually confirmed the fear of authoritarians and showed they have every reason to oppose legal mushrooms. According to the study from the Psychedelic Research Group at Imperial College London, published in the journal Psychopharmacology, psychedelic mushrooms tend to make people more resistant to authority. They also found the psychedelic experience induced by these mushrooms also cause people to be more connected with nature.
“Our findings tentatively raise the possibility that given in this way, psilocybin may produce sustained changes in outlook and political perspective, here in the direction of increased nature relatedness and decreased authoritarianism,” researchers Taylor Lyons and Robin L. Carhart-Harris write in the study.
Now, as people share information globally, instantaneously, on a scale unstoppable by the state, we are resuming the advancement of medical research on psychedelic substances. Scientists are challenging the irrational classification of psychedelics as “class A” (UK) or “schedule 1” (US) substances, characterized as having no medical use and high potential for addiction. And, the recent push in Colorado is evidence of this.
While the stigma associated with mushrooms and other psychedelics has been perpetuated by those who wish to keep them illegal—to keep society in a constant state of obedient mediocrity—in reality, they are extremely safe.
In fact, a major study last year declared magic mushrooms to be the safest recreational drug.
Of an astonishing 120,000 participants from 50 nations, researchers for the Global Drug Survey found the percentage of those seeking emergency treatment for ingesting psilocybin-containing hallucinogenic mushrooms to comprise just 0.2 percent per 10,000 individuals.
Rates of hospitalization for MDMA, alcohol, LSD, and cocaine were an astounding five times higher.
“Magic mushrooms are one of the safest drugs in the world,” Global Drug Survey founder and consultant addiction psychiatrist, Adam Winstock, told the Guardian, noting the biggest risk users face is misidentification — ingesting the wrong mushroom — not from the psychedelic fungus, itself.
After 40 years, it appears that another brick in the wall of prohibition is beginning to crumble in the face of science and logic. There may be hope for humanity after all.